Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,627 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01627067 | Exemestane-RAD001-Metformin | terminated | Phase 2 | 23 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 19, 2020 | clinicaltrials |
| NCT00090480 | Vaccine Treatment for Advanced Breast Cancer | terminated | Phase 1 / Phase 2 | 3 | NewLink Genetics CorporationINDUSTRY | 1 | May 28, 2020 | clinicaltrials |
| NCT04066790 |
| Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer |
| terminated |
| Phase 2 |
| 12 |
| Shanghai Jiao Tong University School of MedicineOTHER |
| 1 |
| May 19, 2020 |
| clinicaltrials |
| NCT02774681 | Palbociclib in Treating Patients With Metastatic HER-2 Positive Breast Cancer With Brain Metastasis | terminated | Phase 2 | 12 | Northwestern UniversityOTHER | 1 | Apr 14, 2020 | clinicaltrials |
| NCT01060345 | A Pilot Study of Chemo-prevention of Green Tea in Women With Ductal Carcinoma in Situ | terminated | Phase 2 | 20 | University of ChicagoOTHER | 1 | Apr 9, 2020 | clinicaltrials |
| NCT03763851 | Cannabis Oil and Radiation Therapy for the Management of Pain | terminated | Phase 2 | 100 | Tetra Bio-PharmaINDUSTRY | 1 | Mar 12, 2020 | clinicaltrials |
| NCT01900730 | Study of Valproic Acid (VPA) vs Placebo to Shorten Time of Indwelling Pleural Catheter | terminated | Phase 2 | 3 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 25, 2020 | clinicaltrials |
| NCT01392352 | HYPAZ: Hypertension Induced by Pazopanib(HYPAZ) | terminated | Phase 2 | 31 | Cambridge University Hospitals NHS Foundation TrustOTHER | 1 | Feb 13, 2020 | clinicaltrials |
| NCT00616122 | Sunitinib, Cyclophosphamide, and Methotrexate in Treating Patients With Metastatic Breast Cancer | terminated | Phase 1 / Phase 2 | 32 | University of California, San FranciscoOTHER | 1 | Jan 13, 2020 | clinicaltrials |
| NCT02003092 | RX-5902 Treatment of Subjects With Triple Negative Breast Cancer | terminated | Phase 1 / Phase 2 | 18 | Rexahn Pharmaceuticals, Inc.INDUSTRY | 1 | Jan 6, 2020 | clinicaltrials |
| NCT01545648 | Pilot Study to Evaluate the Impact of Denosumab on Disseminated Tumor Cells (DTC) in Patients With Early Stage Breast Cancer | terminated | Phase 2 | 4 | Hope Rugo, MDOTHER | 1 | Jan 2, 2020 | clinicaltrials |
| NCT01624090 | Mithramycin for Lung, Esophagus, and Other Chest Cancers | terminated | Phase 2 | 16 | National Cancer Institute (NCI)NIH | 1 | Dec 30, 2019 | clinicaltrials |
| NCT00574236 | Phase II Trial of Bortezomib and Doxorubicin in Metastatic Breast Cancer | terminated | Phase 2 | 4 | University of Wisconsin, MadisonOTHER | 1 | Dec 13, 2019 | clinicaltrials |
| NCT01902823 | Effect of Cancer Nurse Navigators on Patient Outcomes | terminated | Phase 2 / Phase 3 | 16 | University of Wisconsin, MadisonOTHER | 1 | Dec 13, 2019 | clinicaltrials |
| NCT03300843 | Ability of a Dendritic Cell Vaccine to Immunize Melanoma or Epithelial Cancer Patients Against Defined Mutated Neoantigens Expressed by the Autologous Cancer | terminated | Phase 2 | 1 | National Cancer Institute (NCI)NIH | 1 | Dec 13, 2019 | clinicaltrials |
| NCT02538471 | LY2157299 Monohydrate (LY2157299) and Radiotherapy in Metastatic Breast Cancer | terminated | Phase 2 | 3 | Weill Medical College of Cornell UniversityOTHER | 1 | Dec 9, 2019 | clinicaltrials |
| NCT00456846 | First Line Therapy for Patients With Metastatic Breast Cancer | terminated | Phase 2 | 123 | CelgeneINDUSTRY | 1 | Nov 22, 2019 | clinicaltrials |
| NCT01952054 | Denosumab for Breast Cancer With Bone Mets | terminated | Phase 2 | 7 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 22, 2019 | clinicaltrials |
| NCT00531271 | ABI-008 Trial in Patients With Metastatic Breast Cancer | terminated | Phase 1 / Phase 2 | 85 | CelgeneINDUSTRY | 1 | Nov 14, 2019 | clinicaltrials |
| NCT01118975 | GCC 0845:Vorinostat and Lapatinib in Advanced Solid Tumors and Advanced Breast Cancer to Evaluate Response and Biomarkers | terminated | Phase 1 / Phase 2 | 12 | University of Maryland, BaltimoreOTHER | 1 | Nov 13, 2019 | clinicaltrials |
| NCT02318901 | Pembrolizumab and Monoclonal Antibody Therapy in Advanced Cancer(PembroMab) | terminated | Phase 1 / Phase 2 | 16 | Western Regional Medical CenterOTHER | 1 | Oct 21, 2019 | clinicaltrials |
| NCT02472353 | Use of Metformin to Reduce Cardiac Toxicity in Breast Cancer | terminated | Phase 2 | 30 | Avera McKennan Hospital & University Health CenterOTHER | 1 | Oct 16, 2019 | clinicaltrials |
| NCT01370239 | HumanaH - Hu3s193 in the Treatment of Advanced Breast Cancer After Hormonal Therapy | terminated | Phase 2 | 23 | Instituto do Cancer do Estado de São PauloOTHER | 1 | Oct 11, 2019 | clinicaltrials |
| NCT02950480 | Breast Capsular Contracture Following Post-Mastectomy Reconstruction in Women Treated With the Leukotriene Inhibitor Zafirlukast: A Phase II Trial | terminated | Phase 2 | 4 | University of California, San FranciscoOTHER | 1 | Oct 1, 2019 | clinicaltrials |
| NCT01891357 | Phase II Trial to Validate Markers for a Response Evaluation of a Combined Therapy in Patients With HER2+ Breast Cancer | terminated | Phase 2 | 64 | Women's Cancer Study Group GmbHOTHER | 1 | Sep 17, 2019 | clinicaltrials |
| NCT02598310 | Neoadjuvant Nab-PTX and Trastuzumab for ER Negative and HER2 Positive Breast Cancer | terminated | Phase 2 | 30 | Osaka Medical CollegeOTHER | 1 | Aug 28, 2019 | clinicaltrials |
| NCT03318562 | A PD Study of Oral eFT508 in Subjects With Advanced TNBC and HCC | terminated | Phase 2 | 3 | Effector TherapeuticsINDUSTRY | 1 | Jul 18, 2019 | clinicaltrials |
| NCT02389764 | Nintedanib For HER2-Negative Metastatic Inflammatory Breast Cancer (MIBC) | terminated | Phase 2 | 10 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 17, 2019 | clinicaltrials |
| NCT00759642 | Lapatinib in Women With Metastatic Breast Cancer Who Have Failed Prior Antihormone Therapy | terminated | Phase 2 | 33 | University of Kansas Medical CenterOTHER | 1 | Jul 1, 2019 | clinicaltrials |
| NCT01159067 | Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload | terminated | Phase 2 | 1 | City of Hope Medical CenterOTHER | 1 | Jun 18, 2019 | clinicaltrials |
| NCT02153905 | T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-A*01 Positive | terminated | Phase 1 / Phase 2 | 3 | National Cancer Institute (NCI)NIH | 1 | Jun 17, 2019 | clinicaltrials |
| NCT00784524 | Phase II Study of Allo LMI Vaccine With IL-2 for Stable Metastatic Breast Ca | terminated | Phase 2 | 14 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Jun 6, 2019 | clinicaltrials |
| NCT02012608 | Glutamine for the Prevention of Radiation Toxicity in Subjects Conserving Therapy | terminated | Phase 2 | 14 | University of ArkansasOTHER | 1 | May 29, 2019 | clinicaltrials |
| NCT02674204 | STOP Heart Disease in Breast Cancer Survivors Trial(STOP) | terminated | Phase 2 | 2 | Cedars-Sinai Medical CenterOTHER | 1 | May 15, 2019 | clinicaltrials |
| NCT02658084 | Vinorelbine With Trastuzumab Emtansine in Pre-Treated HER2-Positive Metastatic Breast Cancer | terminated | Phase 1 / Phase 2 | 2 | University of MiamiOTHER | 1 | Apr 17, 2019 | clinicaltrials |
| NCT00462865 | Trial of Chemotherapy and Avastin as Treatment for Women With Breast Cancer at High Risk for Relapse | terminated | Phase 2 | 18 | Brown UniversityOTHER | 1 | Apr 9, 2019 | clinicaltrials |
| NCT00080626 | Neoadjuvant Docetaxel in Treating Women With Newly Diagnosed Breast Cancer | terminated | Phase 2 | 19 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Mar 21, 2019 | clinicaltrials |
| NCT00063934 | Oblimersen Plus Doxorubicin and Docetaxel in Treating Patients With Metastatic or Locally Advanced Breast Cancer | terminated | Phase 1 / Phase 2 | 31 | National Cancer Institute (NCI)NIH | 1 | Mar 5, 2019 | clinicaltrials |
| NCT00130507 | Benefit of Adding Trastuzumab to Second Line Chemotherapy in Breast Cancer Patients Previously Treated With Trastuzumab | terminated | Phase 2 | 14 | Spanish Breast Cancer Research GroupOTHER | 1 | Feb 26, 2019 | clinicaltrials |
| NCT00434941 | Capecitabine Plus Radiotherapy for Local Relapse Breast Cancer With Negative Her2 Tumours | terminated | Phase 2 | 1 | Spanish Breast Cancer Research GroupOTHER | 1 | Feb 21, 2019 | clinicaltrials |
| NCT00096369 | Tamoxifen in Preventing Breast Cancer in Women at Increased Risk for Breast Cancer | terminated | Phase 2 | 130 | University of Texas Southwestern Medical CenterOTHER | 1 | Jan 24, 2019 | clinicaltrials |
| NCT01185509 | Trastuzumab and Vinorelbine in Advanced Breast Cancer | terminated | Phase 2 | 31 | Dana-Farber Cancer InstituteOTHER | 1 | Jan 23, 2019 | clinicaltrials |
| NCT02299635 | A Study Evaluating PF-03084014 In Patients With Advanced Breast Cancer With Or Without Notch Alterations | terminated | Phase 2 | 19 | PfizerINDUSTRY | 6 | Jan 8, 2019 | clinicaltrials |
| NCT01912963 | Phase II Study of Eribulin Mesylate, Trastuzumab, and Pertuzumab in Women With Metastatic, Unresectable Locally Advanced, or Locally Recurrent HER2-Positive Breast Cancer | terminated | Phase 2 | 32 | Dana-Farber Cancer InstituteOTHER | 1 | Dec 5, 2018 | clinicaltrials |
| NCT03070002 | Denosumab in Treating Patients With ER and/or PR Positive, HER2 Negative Metastatic Breast Cancer With Bone Metastases and Detectable Circulating Tumor Cells | terminated | Phase 2 | 1 | Northwestern UniversityOTHER | 1 | Nov 20, 2018 | clinicaltrials |
| NCT02347163 | Pre-operative Zoledronate in Triple Negative Breast Cancer | terminated | Phase 2 | 22 | Mario Negri Institute for Pharmacological ResearchOTHER | 1 | Nov 6, 2018 | clinicaltrials |
| NCT02669914 | MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors | terminated | Phase 2 | 4 | Washington University School of MedicineOTHER | 1 | Nov 6, 2018 | clinicaltrials |
| NCT00214149 | Multi-catheter High Dose Rate (HDR) Breast Brachytherapy | terminated | Phase 2 | 127 | University of Wisconsin, MadisonOTHER | 1 | Nov 5, 2018 | clinicaltrials |
| NCT02375048 | Randomized Study on Postmenopausal Women With Early Stage Breast Cancer: WBI Versus APBI | terminated | Phase 2 | 179 | Istituto Clinico HumanitasOTHER | 1 | Oct 24, 2018 | clinicaltrials |
Data updated 23 days agoSource updated Jun 19, 2020source: clinicaltrials